The presence of TaqI and FokI SNPs in HCV+ patients may have an impact on liver cell metabolic plasticity and liver cancer development, considering that they are linked to the expression of genes encoding lysine-specific histone demethylase 2 (LSD2) and cyclin-dependent kinase inhibitor 1B (p27). Here, KDM1B is linked to liver cancer.